New Drug Daraxonrasib Nearly Doubles Survival in Pancreatic Cancer Breakthrough
A once-undruggable cancer driver has finally been targeted, cutting death risk by 60% in a landmark 500-patient trial.
20 articles
A once-undruggable cancer driver has finally been targeted, cutting death risk by 60% in a landmark 500-patient trial.
A protein called HOXD13 drives skin cancer growth and shields tumors from immune cells β disabling it could unlock powerful new treatments.
New trial data reveals AstraZeneca's experimental in vivo CAR-T therapy showed early responses in multiple myeloma patients but resulted in one death.
Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.
Mouse study reveals the FXR bile acid receptor links gut microbes to arterial plaque in sleep apnea, hinting at new preventive targets.
Australian biotech company creates targeted treatment that attacks malignant plasma cells while sparing healthy ones in multiple myeloma patients.
New study shows PCSK9 inhibitor prevents cardiovascular events in high-risk diabetes patients without existing heart disease.
A landmark study of 500 cat tumors reveals shared cancer-driving mutations with humans, pointing toward new breast cancer treatments.
Scientists found drugs that kill senescent 'zombie cells' by blocking their key survival protein, shrinking tumors in mice.
A new DNA-based treatment blocks the PCSK9 protein, cutting LDL cholesterol by nearly 50% while avoiding common statin side effects.
Scientists discover why identical cancer treatments work for some patients but fail for others, revealing hidden drug reservoirs in cells.
Redesigned immunotherapy injected into one tumor triggered complete cancer remission in 2 of 12 patients, with untreated tumors also disappearing.
Plant compounds naturally target multiple cancer pathways simultaneously, offering advantages over pharmaceutical approaches.
Breakthrough blood test combining four biomarkers catches deadly pancreatic cancer early when treatment works best, detecting 87.5% of stage I/II cases.
McGill scientists boosted NK cell cancer-killing power using reversible drug treatment, targeting leukemia, glioblastoma, and triple-negative breast cancer.
A newly identified molecule called SLAMF6 exhausts cancer-fighting T cells from within β and blocking it may revive failed immunotherapies.
New biotech innovations are advancing prostate cancer therapy with promising approaches for better patient outcomes.
Scientists discover how small cell lung cancer uses inflammation to become more aggressive and resistant to treatment.
When the DNA-repair gene EXO1 is overproduced, it damages DNA instead of fixing itβexposing a hidden vulnerability in multiple cancers.
New research reveals colorectal cancer has distinct microbial communities that could improve diagnosis and personalized treatment approaches.